152 related articles for article (PubMed ID: 38132395)
1. Regulatory and Interacting Partners of PDLIM7 in Thyroid Cancer.
Rood K; Yamauchi CR; Sharma U; Laxa RT; Robins C; Lanza G; Sánchez-Ruiz K; Khan A; Kim HS; Shields A; Kennedy K; Mirshahidi S; Perez MC; Firek A; Munir I; Simental AA; Khan S
Curr Oncol; 2023 Dec; 30(12):10450-10462. PubMed ID: 38132395
[TBL] [Abstract][Full Text] [Related]
2. Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin.
Kim YJ; Hwang HJ; Kang JG; Kim CS; Ihm SH; Choi MG; Lee SJ
Anticancer Res; 2018 Jun; 38(6):3515-3525. PubMed ID: 29848705
[TBL] [Abstract][Full Text] [Related]
3. Pathologic significance of a novel oncoprotein in thyroid cancer progression.
Firek AA; Perez MC; Gonda A; Lei L; Munir I; Simental AA; Carr FE; Becerra BJ; De Leon M; Khan S
Head Neck; 2017 Dec; 39(12):2459-2469. PubMed ID: 29024261
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
Int J Oncol; 2019 Jan; 54(1):315-325. PubMed ID: 30387841
[TBL] [Abstract][Full Text] [Related]
5. CircNDST1 promotes papillary thyroid cancer progression via its interaction with CSNK2A1 to activate the PI3K-Akt pathway and epithelial-mesenchymal transition.
Shu C; Wang S; Hu J; Xu M; Deng H; Maimaiti Y; Huang T
J Endocrinol Invest; 2023 Mar; 46(3):545-557. PubMed ID: 36306106
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
7. LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling.
Liu H; Deng H; Zhao Y; Li C; Liang Y
J Exp Clin Cancer Res; 2018 Nov; 37(1):279. PubMed ID: 30463570
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.
Wu YC; Li SY; Jia YF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481
[TBL] [Abstract][Full Text] [Related]
9. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
10. A single nuclear polymorphism in let-7g binding site affects the doubling time of thyroid nodule by regulating KRAS-induced cell proliferation.
Liu A; Zhang W; Zhao T; Xiao M; Mei Q; Zhu H
J Cell Physiol; 2019 Dec; 234(12):23437-23447. PubMed ID: 31152438
[TBL] [Abstract][Full Text] [Related]
11. Significance of LINC02082 and LOC105369812 in differentiating papillary thyroid cancer from benign nodules.
Xu J; Liu W; Li R; Wang Y
Medicine (Baltimore); 2023 Nov; 102(44):e35542. PubMed ID: 37932992
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA LINC003121 Inhibits Proliferation and Invasion of Thyroid Cancer Cells by Suppression of the Phosphatidylinositol-3-Kinase (PI3K)/Akt Signaling Pathway.
Min X; Liu K; Zhu H; Zhang J
Med Sci Monit; 2018 Jul; 24():4592-4601. PubMed ID: 29969438
[TBL] [Abstract][Full Text] [Related]
13. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
[TBL] [Abstract][Full Text] [Related]
14. miRNA‑148a inhibits cell growth of papillary thyroid cancer through STAT3 and PI3K/AKT signaling pathways.
Xu Y; Han YF; Zhu SJ; Dong JD; Ye B
Oncol Rep; 2017 Nov; 38(5):3085-3093. PubMed ID: 28901486
[TBL] [Abstract][Full Text] [Related]
15. Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion.
Gao W; Han J
Oncol Res; 2017 Jul; 25(6):879-886. PubMed ID: 27938497
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-126 suppresses proliferation of undifferentiated (BRAF(V600E) and BRAF(WT)) thyroid carcinoma through targeting PIK3R2 gene and repressing PI3K-AKT proliferation-survival signalling pathway.
Rahman MA; Salajegheh A; Smith RA; Lam AK
Exp Cell Res; 2015 Dec; 339(2):342-50. PubMed ID: 26384552
[TBL] [Abstract][Full Text] [Related]
17. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
18. miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma.
Zang C; Sun J; Liu W; Chu C; Jiang L; Ge R
Hum Cell; 2019 Oct; 32(4):428-436. PubMed ID: 31161410
[TBL] [Abstract][Full Text] [Related]
19. Circ_100395 impedes malignancy and glycolysis in papillary thyroid cancer: Involvement of PI3K/AKT/mTOR signaling pathway.
Chen L; Zhuo D; Yuan H
Immunol Lett; 2022 Jun; 246():10-17. PubMed ID: 35447227
[TBL] [Abstract][Full Text] [Related]
20. Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway.
Luo X; Wang J; Lu J; Wang X; Miao Y; Li Q; Li X; Wang L
Biomed Res Int; 2022; 2022():1874550. PubMed ID: 35757470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
